Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 436 results found. Search for [ coronavirus vaccine developed in India ]

Results 100 to 120 of 436
Reuters
October 1, 2020
AstraZeneca's large, late-stage U.S. trial has remained on hold since Sept. 6, after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 27, 2020
Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians


BusinessToday.In
September 26, 2020
Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country


Joe C Mathew
September 26, 2020
Researchers say frontline healthcare workers have more than threefold higher risk of COVID-19 infection than general community; they also face critical PPE shortage while dealing with highest caseloads


BusinessToday.In
September 23, 2020
Pharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine


BusinessToday.In
September 23, 2020
Phase 1 clinical trial of Codagenix' intranasal, live-attenuated vaccine candidate for SARS-CoV-2, is expected to initiate in the United Kingdom by the end of 2020


BusinessToday.In
September 23, 2020
This inoculation adds to Bharat Biotech's portfolio of vaccines currently being developed by it and are in several stages of clinical development, comprising COVAXIN- which is India's first indigenous vaccine against coronavirus


Rashi Bisaria
New Delhi, September 21, 2020
Farm bills passed in Rajya Sabha amid protests by opposition MPsThe Rajya Sabha has passed the Farmers' and Produce Trade and Commerce (Promotion and Facilitation) Bill, 2020 and Farmers (Empowerment and Protection) Agreement on Price Assurance and Farm Services Bill, 2020, through voice vote amid protest by opposition MPs and farmers' protests across Punjab and Haryana. The bills were passed in the Lok Sabha last week.Tata Consultancy Services sets up 11 COVID-19 isolation centres for staf...


BusinessToday.In
September 20, 2020
AstraZeneca's trial blueprint says that its goal is to develop a vaccine with 50 per cent effectiveness


BusinessToday.In
September 20, 2020
Tata CRISPR test meets high-quality benchmarks with 96 per cent sensitivity and 98 per cent specificity (accuracy) for detecting coronavirus; it shows result more quickly than traditional RT-PCR test kits and is less expensive


BusinessToday.In
September 19, 2020
The final clinical trial of coronavirus vaccine by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune from Monday


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


Sonal Khetarpal
September 17, 2020
IIT Madras was working for the last nine years on a fiber optic biosensor platform for for tuberculosis diagnosis. This technology is now being modified to determine antigen in the saliva for COVID-19 infection


BusinessToday.In
September 17, 2020
Dr Reddy's Laboratories stock which closed 4.24% higher in the previous session gained 4.21% or Rs 195 to close at Rs 4,826 on BSE today


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


Joe C Mathew
September 16, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, a joint statement issued by RDIF and Dr Reddy's says


BusinessToday.In
September 16, 2020
Dr Reddy's Lab share touched an intraday high of Rs 4651.95, a rise of 4.7% on BSE


Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


PAGES 6 OF 22  678910